What is the P/E ratio of Universal Biosensors 2024?
The Universal Biosensors P/E ratio is -2.88.
Access the world's leading financial data and tools
Subscribe for $2 
Overview
Profile
Universal Biosensors stock stock price, forecast, news, chart, split, dividend and analysis Universal Biosensors ariva, Universal Biosensors onvista, Universal Biosensors finanzen.net, Universal Biosensors aktienfinder, Universal Biosensors marketscreener, Universal Biosensors marketwatch, Universal Biosensors bloomberg, Universal Biosensors handelsblatt, Universal Biosensors wiwo, Universal Biosensors forum
UBI.AX
AU000000UBI2
Price
Price
0.12
Today +/-
+0
Today %
+0 %
TickerUBI.AX
ISINAU000000UBI2
P
Universal Biosensors stock price
%
Weekly
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the Universal Biosensors stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the Universal Biosensors stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the Universal Biosensors stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze Universal Biosensors's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
Universal Biosensors Stock Price History
| Date | Universal Biosensors Price |
|---|---|
| 11/15/2024 | 0.12 undefined |
| 11/14/2024 | 0.12 undefined |
| 11/13/2024 | 0.13 undefined |
| 11/12/2024 | 0.13 undefined |
| 11/11/2024 | 0.13 undefined |
| 11/8/2024 | 0.13 undefined |
| 11/7/2024 | 0.13 undefined |
| 11/6/2024 | 0.14 undefined |
| 11/5/2024 | 0.13 undefined |
| 11/4/2024 | 0.13 undefined |
| 11/1/2024 | 0.13 undefined |
| 10/31/2024 | 0.13 undefined |
| 10/30/2024 | 0.12 undefined |
| 10/29/2024 | 0.13 undefined |
| 10/28/2024 | 0.13 undefined |
| 10/25/2024 | 0.14 undefined |
| 10/24/2024 | 0.14 undefined |
| 10/23/2024 | 0.14 undefined |
| 10/22/2024 | 0.15 undefined |
| 10/21/2024 | 0.15 undefined |
| 10/18/2024 | 0.13 undefined |
Universal Biosensors Revenue, EBIT, Net Income AU000000UBI2 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Universal Biosensors, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Universal Biosensors from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Universal Biosensors’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Universal Biosensors. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Universal Biosensors’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Universal Biosensors’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Universal Biosensors’s growth potential.
Universal Biosensors Revenue, EBIT and net profit per share
| Date | Universal Biosensors Revenue | Universal Biosensors EBIT | Universal Biosensors Net Income |
|---|---|---|---|
| 2025e | 21.12 M undefined | -3.7 M undefined | -5.31 M undefined |
| 2024e | 11.36 M undefined | -6.77 M undefined | -9.36 M undefined |
| 2023 | 6.63 M undefined | -16.68 M undefined | -6.74 M undefined |
| 2022 | 4.52 M undefined | -23.88 M undefined | -26.85 M undefined |
| 2021 | 5.78 M undefined | -15.04 M undefined | -10.51 M undefined |
| 2020 | 3.2 M undefined | -12.56 M undefined | -7.64 M undefined |
| 2019 | 6.9 M undefined | -10.4 M undefined | -4.85 M undefined |
| 2018 | 69.46 M undefined | 46.42 M undefined | 37.56 M undefined |
| 2017 | 25.19 M undefined | 1.02 M undefined | -764,720 undefined |
| 2016 | 18.83 M undefined | -3.72 M undefined | 1.25 M undefined |
| 2015 | 16.77 M undefined | -10.4 M undefined | -6.58 M undefined |
| 2014 | 9.53 M undefined | -13.79 M undefined | -9.32 M undefined |
| 2013 | 15.09 M undefined | -18.24 M undefined | -11.63 M undefined |
| 2012 | 29.65 M undefined | -9.28 M undefined | -9.13 M undefined |
| 2011 | 14.7 M undefined | -15.41 M undefined | -14.69 M undefined |
| 2010 | 18.18 M undefined | -7.77 M undefined | -6.61 M undefined |
| 2009 | 22.04 M undefined | 880,000 undefined | 1.43 M undefined |
| 2008 | 3.12 M undefined | -17.1 M undefined | -12 M undefined |
| 2007 | 0 undefined | -11.58 M undefined | -8.81 M undefined |
| 2006 | 0 undefined | -5.93 M undefined | -2.95 M undefined |
| 2005 | 0 undefined | -3.54 M undefined | -60,000 undefined |
| 2004 | 0 undefined | -2.7 M undefined | -200,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 0 AUD | -2.7 M AUD | -200,000 AUD |
| 2005 | 0 AUD | -3.54 M AUD | -60,000 AUD |
| 2006 | 0 AUD | -5.93 M AUD | -2.95 M AUD |
| 2007 | 0 AUD | -11.58 M AUD | -8.81 M AUD |
| 2008 | 3.12 M AUD | -17.1 M AUD | -12 M AUD |
| 2009 | 22.04 M AUD | 880,000 AUD | 1.43 M AUD |
| 2010 | 18.18 M AUD | -7.77 M AUD | -6.61 M AUD |
| 2011 | 14.7 M AUD | -15.41 M AUD | -14.69 M AUD |
| 2012 | 29.65 M AUD | -9.28 M AUD | -9.13 M AUD |
| 2013 | 15.09 M AUD | -18.24 M AUD | -11.63 M AUD |
| 2014 | 9.53 M AUD | -13.79 M AUD | -9.32 M AUD |
| 2015 | 16.77 M AUD | -10.4 M AUD | -6.58 M AUD |
| 2016 | 18.83 M AUD | -3.72 M AUD | 1.25 M AUD |
| 2017 | 25.19 M AUD | 1.02 M AUD | -764,720 AUD |
| 2018 | 69.46 M AUD | 46.42 M AUD | 37.56 M AUD |
| 2019 | 6.9 M AUD | -10.4 M AUD | -4.85 M AUD |
| 2020 | 3.2 M AUD | -12.56 M AUD | -7.64 M AUD |
| 2021 | 5.78 M AUD | -15.04 M AUD | -10.51 M AUD |
| 2022 | 4.52 M AUD | -23.88 M AUD | -26.85 M AUD |
| 2023 | 6.63 M AUD | -16.68 M AUD | -6.74 M AUD |
| 2024e | 11.36 M AUD | -6.77 M AUD | -9.36 M AUD |
| 2025e | 21.12 M AUD | -3.7 M AUD | -5.31 M AUD |
Universal Biosensors Income Statement, Balance Sheet, Cash Flow Statement
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 3 | 22 | 18 | 14 | 29 | 15 | 9 | 16 | 18 | 25 | 69 | 6 | 3 | 5 | 4 | 6 | 11 | 21 |
| - | - | - | - | - | - | - | 633.33 | -18.18 | -22.22 | 107.14 | -48.28 | -40.00 | 77.78 | 12.50 | 38.89 | 176.00 | -91.30 | -50.00 | 66.67 | -20.00 | 50.00 | 83.33 | 90.91 |
| - | - | - | - | - | - | 133.33 | 95.45 | 27.78 | 7.14 | 34.48 | 20.00 | 88.89 | 93.75 | 94.44 | 84.00 | 95.65 | 50.00 | 133.33 | 40.00 | 50.00 | 66.67 | 36.36 | 19.05 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 5 | 1 | 10 | 3 | 8 | 15 | 17 | 21 | 66 | 3 | 0 | 2 | 2 | 4 | 0 | 0 |
| 0 | 0 | 0 | 0 | -2 | -8 | -12 | 1 | -6 | -14 | -9 | -11 | -9 | -6 | 1 | 0 | 37 | -4 | -7 | -10 | -26 | -6 | -9 | -5 |
| - | - | - | - | - | 300.00 | 50.00 | -108.33 | -700.00 | 133.33 | -35.71 | 22.22 | -18.18 | -33.33 | -116.67 | - | - | -110.81 | 75.00 | 42.86 | 160.00 | -76.92 | 50.00 | -44.44 |
| 30.7 | 45.8 | 45.8 | 47.95 | 51.99 | 129.64 | 156.97 | 161.35 | 157.58 | 159.02 | 160.42 | 174.43 | 175.61 | 175.88 | 177.37 | 176.42 | 177.15 | 177.48 | 177.57 | 188.24 | 210.49 | 224.94 | 0 | 0 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The Universal Biosensors Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Universal Biosensors is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Universal Biosensors stock margins AU000000UBI2 ·
The Universal Biosensors margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Universal Biosensors. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Universal Biosensors.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Universal Biosensors's sales revenue. A higher gross margin percentage indicates that the Universal Biosensors retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Universal Biosensors's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Universal Biosensors's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Universal Biosensors's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Universal Biosensors. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Universal Biosensors's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Universal Biosensors Margin History
| Universal Biosensors Gross margin | Universal Biosensors Profit margin | Universal Biosensors EBIT margin | Universal Biosensors Profit margin |
|---|---|---|---|
| 2025e | 64.6 % | -17.52 % | -25.14 % |
| 2024e | 64.6 % | -59.6 % | -82.34 % |
| 2023 | 64.6 % | -251.48 % | -101.64 % |
| 2022 | 47.27 % | -527.72 % | -593.48 % |
| 2021 | 36.44 % | -260.28 % | -181.85 % |
| 2020 | 19.46 % | -392.12 % | -238.49 % |
| 2019 | 48.22 % | -150.78 % | -70.26 % |
| 2018 | 96.38 % | 66.84 % | 54.08 % |
| 2017 | 84.32 % | 4.03 % | -3.04 % |
| 2016 | 93.88 % | -19.77 % | 6.64 % |
| 2015 | 91.77 % | -61.98 % | -39.2 % |
| 2014 | 94.17 % | -144.66 % | -97.76 % |
| 2013 | 22.86 % | -120.87 % | -77.07 % |
| 2012 | 37.07 % | -31.3 % | -30.79 % |
| 2011 | 11.43 % | -104.83 % | -99.93 % |
| 2010 | 32.45 % | -42.74 % | -36.36 % |
| 2009 | 97.19 % | 3.99 % | 6.49 % |
| 2008 | 64.6 % | -548.08 % | -384.62 % |
| 2007 | 64.6 % | 0 % | 0 % |
| 2006 | 64.6 % | 0 % | 0 % |
| 2005 | 64.6 % | 0 % | 0 % |
| 2004 | 64.6 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 64.6 % | 0 % | 0 % |
| 2005 | 64.6 % | 0 % | 0 % |
| 2006 | 64.6 % | 0 % | 0 % |
| 2007 | 64.6 % | 0 % | 0 % |
| 2008 | 64.6 % | -548.08 % | -384.62 % |
| 2009 | 97.19 % | 3.99 % | 6.49 % |
| 2010 | 32.45 % | -42.74 % | -36.36 % |
| 2011 | 11.43 % | -104.83 % | -99.93 % |
| 2012 | 37.07 % | -31.3 % | -30.79 % |
| 2013 | 22.86 % | -120.87 % | -77.07 % |
| 2014 | 94.17 % | -144.66 % | -97.76 % |
| 2015 | 91.77 % | -61.98 % | -39.2 % |
| 2016 | 93.88 % | -19.77 % | 6.64 % |
| 2017 | 84.32 % | 4.03 % | -3.04 % |
| 2018 | 96.38 % | 66.84 % | 54.08 % |
| 2019 | 48.22 % | -150.78 % | -70.26 % |
| 2020 | 19.46 % | -392.12 % | -238.49 % |
| 2021 | 36.44 % | -260.28 % | -181.85 % |
| 2022 | 47.27 % | -527.72 % | -593.48 % |
| 2023 | 64.6 % | -251.48 % | -101.64 % |
| 2024e | 64.6 % | -59.6 % | -82.34 % |
| 2025e | 64.6 % | -17.52 % | -25.14 % |
Universal Biosensors Stock Sales Revenue, EBIT, Earnings per Share AU000000UBI2 ·
The Universal Biosensors earnings per share therefore indicates how much revenue Universal Biosensors has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
25 Years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Universal Biosensors earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Universal Biosensors's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Universal Biosensors’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Universal Biosensors's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
Universal Biosensors Revenue, EBIT and net profit per share
| Date | Universal Biosensors Sales per Share | Universal Biosensors EBIT per share | Universal Biosensors Earnings per Share |
|---|---|---|---|
| 2025e | 0.07 undefined | 0 undefined | -0.02 undefined |
| 2024e | 0.04 undefined | 0 undefined | -0.03 undefined |
| 2023 | 0.03 undefined | -0.07 undefined | -0.03 undefined |
| 2022 | 0.02 undefined | -0.11 undefined | -0.13 undefined |
| 2021 | 0.03 undefined | -0.08 undefined | -0.06 undefined |
| 2020 | 0.02 undefined | -0.07 undefined | -0.04 undefined |
| 2019 | 0.04 undefined | -0.06 undefined | -0.03 undefined |
| 2018 | 0.39 undefined | 0.26 undefined | 0.21 undefined |
| 2017 | 0.14 undefined | 0.01 undefined | -0 undefined |
| 2016 | 0.11 undefined | -0.02 undefined | 0.01 undefined |
| 2015 | 0.1 undefined | -0.06 undefined | -0.04 undefined |
| 2014 | 0.05 undefined | -0.08 undefined | -0.05 undefined |
| 2013 | 0.09 undefined | -0.1 undefined | -0.07 undefined |
| 2012 | 0.18 undefined | -0.06 undefined | -0.06 undefined |
| 2011 | 0.09 undefined | -0.1 undefined | -0.09 undefined |
| 2010 | 0.12 undefined | -0.05 undefined | -0.04 undefined |
| 2009 | 0.14 undefined | 0.01 undefined | 0.01 undefined |
| 2008 | 0.02 undefined | -0.11 undefined | -0.08 undefined |
| 2007 | 0 undefined | -0.09 undefined | -0.07 undefined |
| 2006 | 0 undefined | -0.11 undefined | -0.06 undefined |
| 2005 | 0 undefined | -0.07 undefined | -0 undefined |
| 2004 | 0 undefined | -0.06 undefined | -0 undefined |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2004 | 0 AUD | -0.06 AUD | -0 AUD |
| 2005 | 0 AUD | -0.07 AUD | -0 AUD |
| 2006 | 0 AUD | -0.11 AUD | -0.06 AUD |
| 2007 | 0 AUD | -0.09 AUD | -0.07 AUD |
| 2008 | 0.02 AUD | -0.11 AUD | -0.08 AUD |
| 2009 | 0.14 AUD | 0.01 AUD | 0.01 AUD |
| 2010 | 0.12 AUD | -0.05 AUD | -0.04 AUD |
| 2011 | 0.09 AUD | -0.1 AUD | -0.09 AUD |
| 2012 | 0.18 AUD | -0.06 AUD | -0.06 AUD |
| 2013 | 0.09 AUD | -0.1 AUD | -0.07 AUD |
| 2014 | 0.05 AUD | -0.08 AUD | -0.05 AUD |
| 2015 | 0.1 AUD | -0.06 AUD | -0.04 AUD |
| 2016 | 0.11 AUD | -0.02 AUD | 0.01 AUD |
| 2017 | 0.14 AUD | 0.01 AUD | -0 AUD |
| 2018 | 0.39 AUD | 0.26 AUD | 0.21 AUD |
| 2019 | 0.04 AUD | -0.06 AUD | -0.03 AUD |
| 2020 | 0.02 AUD | -0.07 AUD | -0.04 AUD |
| 2021 | 0.03 AUD | -0.08 AUD | -0.06 AUD |
| 2022 | 0.02 AUD | -0.11 AUD | -0.13 AUD |
| 2023 | 0.03 AUD | -0.07 AUD | -0.03 AUD |
| 2024e | 0.04 AUD | 0 AUD | -0.03 AUD |
| 2025e | 0.07 AUD | 0 AUD | -0.02 AUD |
Universal Biosensors business model
Universal Biosensors is one of the most popular companies on Eulerpool.com.
Universal Biosensors Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
Universal Biosensors historical P/E ratio, EBIT multiple, and P/S ratio
Universal Biosensors shares outstanding AU000000UBI2 ·
The number of shares was Universal Biosensors in 2023 — This indicates how many shares 224.944 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Universal Biosensors earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Universal Biosensors's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Universal Biosensors’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Universal Biosensors's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 45.8 M Aktien |
| 2005 | 47.95 M Aktien |
| 2006 | 51.99 M Aktien |
| 2007 | 129.64 M Aktien |
| 2008 | 156.97 M Aktien |
| 2009 | 161.35 M Aktien |
| 2010 | 157.58 M Aktien |
| 2011 | 159.02 M Aktien |
| 2012 | 160.42 M Aktien |
| 2013 | 174.43 M Aktien |
| 2014 | 175.61 M Aktien |
| 2015 | 175.88 M Aktien |
| 2016 | 177.37 M Aktien |
| 2017 | 176.42 M Aktien |
| 2018 | 177.15 M Aktien |
| 2019 | 177.48 M Aktien |
| 2020 | 177.57 M Aktien |
| 2021 | 188.24 M Aktien |
| 2022 | 210.49 M Aktien |
| 2023 | 224.94 M Aktien |
| 2024e | 224.94 M Aktien |
| 2025e | 224.94 M Aktien |
Unfortunately, there are currently no price targets and forecasts available for Universal Biosensors.
Universal Biosensors latest earnings and earnings surprises
| Date | EPS Estimate | EPS Actual | Quarterly report |
|---|---|---|---|
| 12/31/2021 | -0.03 | -0.03 (15.21 %) | 2021 Q4 |
| 6/30/2021 | -0.02 | -0.01 (23.08 %) | 2021 Q2 |
1
Universal Biosensors shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 29.35890 % | Viburnum Funds Pty Ltd | 87,509,318 | 30,710,717 | 5/27/2024 |
| 8.42091 % | Hancock & Gore Ltd | 25,100,000 | 8,433,333 | 5/28/2024 |
| 7.58757 % | Richmond Hill Capital Pty. Ltd. | 22,616,067 | 5,011,445 | 4/4/2024 |
| 5.82568 % | Jencay Capital Pty Ltd | 17,364,455 | 0 | 4/4/2024 |
| 0.57735 % | Sharman (John Stewart) | 1,720,883 | 0 | 4/4/2024 |
| 0.36237 % | Mclean (Graham A) | 1,080,116 | 455,116 | 5/27/2024 |
| 0.32570 % | Coleman (Craig Evan) | 970,802 | 217,182 | 5/27/2024 |
| 0.22223 % | Hoey (David L) | 662,397 | 0 | 4/4/2024 |
| 0.14858 % | Smith (Judith Ann) | 442,873 | 99,077 | 5/3/2024 |
| 0.13036 % | Balak (Salesh) | 388,558 | 0 | 4/4/2024 |
1
Universal Biosensors Executives and Management Board
Mr. John Sharman(56)
Universal Biosensors Chief Executive Officer
Compensation 532,423
Mr. Salesh Balak(53)
Universal Biosensors Chief Financial Officer, Company Secretary
Compensation 303,899
Mr. Craig Coleman(57)
Universal Biosensors Non-Executive Director
Compensation 91,067
Ms. Judith Smith(67)
Universal Biosensors Non-Executive Independent Director
Compensation 85,554
Mr. David Hoey(63)
Universal Biosensors Non-Executive Independent Director
Compensation 77,600
1
2
Universal Biosensors Supply Chain
| Name | Relationship | Two-week correlation | One-month correlation | Three-Month Correlation | Six-Month Correlation | One Year Correlation | Two-Year Correlation |
|---|---|---|---|---|---|---|---|
| SupplierCustomer | 0,34 | 0,77 | -0,61 | -0,57 | -0,48 | 0,62 | |
| SupplierCustomer | 0,13 | 0,29 | 0,80 | 0,72 | 0,40 | 0,79 | |
| SupplierCustomer | -0,08 | 0,52 | 0,19 | -0,21 | -0,03 | 0,65 | |
| SupplierCustomer | -0,20 | 0,17 | 0,72 | 0,72 | 0,65 | 0,87 | |
| SupplierCustomer | -0,59 | 0,74 | -0,75 | -0,76 | -0,54 | -0,31 |
1
Most common questions regarding Universal Biosensors
What is the P/S ratio of Universal Biosensors 2024?
The Universal Biosensors P/S ratio is 2.38.
What is the Quality Investing of Universal Biosensors?
The Quality Investing for Universal Biosensors is 4/10.
What is the revenue of Universal Biosensors 2024?
The expected Universal Biosensors revenue is 11.36 M AUD.
How high is the profit of Universal Biosensors 2024?
The expected Universal Biosensors profit is -9.36 M AUD.
What is the business model of Universal Biosensors
No history available for Universal Biosensors.
What is the Universal Biosensors dividend?
Universal Biosensors pays a dividend of 0 AUD distributed over payouts per year.
How often does Universal Biosensors pay dividends?
The dividend cannot currently be calculated for Universal Biosensors or the company does not pay out a dividend.
What is the Universal Biosensors ISIN?
The ISIN of Universal Biosensors is AU000000UBI2.
What is the Universal Biosensors ticker?
The ticker of Universal Biosensors is UBI.AX.
How much dividend does Universal Biosensors pay?
Over the past 12 months, Universal Biosensors paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Universal Biosensors is expected to pay a dividend of 0 AUD.
What is the dividend yield of Universal Biosensors?
The current dividend yield of Universal Biosensors is .
When does Universal Biosensors pay dividends?
Universal Biosensors pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Universal Biosensors?
Universal Biosensors paid dividends every year for the past 0 years.
What is the dividend of Universal Biosensors?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Universal Biosensors located?
Universal Biosensors is assigned to the 'Health' sector.
Wann musste ich die Aktien von Universal Biosensors kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Universal Biosensors from 11/16/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.
When did Universal Biosensors pay the last dividend?
The last dividend was paid out on 11/16/2024.
What was the dividend of Universal Biosensors in the year 2023?
In the year 2023, Universal Biosensors distributed 0 AUD as dividends.
In which currency does Universal Biosensors pay out the dividend?
The dividends of Universal Biosensors are distributed in AUD.
Universal Biosensors stock
Sector
Health
Industry
Health Care Equipment
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website Universal Biosensors
Country
Australia 🇦🇺
Currency
AUD
Initial public offering
Dec 13, 2006
GOSIN
Global Open Securities Identification Number
Cusip
U9145P108
Market capitalization
Quality Investing
4 / 10Details
PEG
0
P/E ratio
Forward P/E ratio
-3.82
P/S ratio
Forward P/S ratio
1.28
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
Universal Biosensors Peer Group
Universal Biosensors Eulerpool News
Universal Biosensors News
All fundamentals about Universal Biosensors
Our stock analysis for Universal Biosensors Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Universal Biosensors Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Universal Biosensors Revenue
- Universal Biosensors Net Income
- Universal Biosensors P/E
- Universal Biosensors P/S
- Universal Biosensors EBIT
- Universal Biosensors Dividend
- Universal Biosensors Stocks
- Universal Biosensors Market capitalization
- Universal Biosensors Debt
- Universal Biosensors Liabilities
- Universal Biosensors Equity
- Universal Biosensors AAQS
- Universal Biosensors Employees
- Universal Biosensors ROE
- Universal Biosensors ROA
- Universal Biosensors ROCE